Review



mouse anti human tlr4 fitc  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology mouse anti human tlr4 fitc
    Mouse Anti Human Tlr4 Fitc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 833 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human tlr4 fitc/product/Santa Cruz Biotechnology
    Average 96 stars, based on 833 article reviews
    mouse anti human tlr4 fitc - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    tlr4 ab invivogen mabg1 ctrlm fitc anti human p2ry12 antibody biolegend 392108 pe mouse anti human cd41a gpiib  (InvivoGen)
    94
    InvivoGen tlr4 ab invivogen mabg1 ctrlm fitc anti human p2ry12 antibody biolegend 392108 pe mouse anti human cd41a gpiib
    Tlr4 Ab Invivogen Mabg1 Ctrlm Fitc Anti Human P2ry12 Antibody Biolegend 392108 Pe Mouse Anti Human Cd41a Gpiib, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tlr4 ab invivogen mabg1 ctrlm fitc anti human p2ry12 antibody biolegend 392108 pe mouse anti human cd41a gpiib/product/InvivoGen
    Average 94 stars, based on 1 article reviews
    tlr4 ab invivogen mabg1 ctrlm fitc anti human p2ry12 antibody biolegend 392108 pe mouse anti human cd41a gpiib - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    mouse anti human tlr4 fitc  (Novus Biologicals)
    94
    Novus Biologicals mouse anti human tlr4 fitc
    Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed over a 10-day time course after admission (emergency department, ED–10) by flow cytometry. Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2 expression in CD14 + monocytes, (b) <t>TLR4</t> expression in CD14 + monocytes, (c) TLR9 expression in CD14 + monocytes, (d) TLR2 expression in CD14 + HLA-DR − monocytes, (e) TLR4 expression in CD14 + HLA-DR − monocytes, and (f) TLR9 expression in CD14 + HLA-DR − monocytes. ∗ p < 0.05 versus unstimulated HV; ⌀ p < 0.05 versus stimulated HV; æ p < 0.05 TP versus corresponding TP stim; # p < 0.05 HV ctrl versus all; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.
    Mouse Anti Human Tlr4 Fitc, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human tlr4 fitc/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    mouse anti human tlr4 fitc - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    mouse anti human tlr4 fitc  (Santa Cruz Biotechnology)
    96
    Santa Cruz Biotechnology mouse anti human tlr4 fitc
    Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed over a 10-day time course after admission (emergency department, ED–10) by flow cytometry. Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2 expression in CD14 + monocytes, (b) <t>TLR4</t> expression in CD14 + monocytes, (c) TLR9 expression in CD14 + monocytes, (d) TLR2 expression in CD14 + HLA-DR − monocytes, (e) TLR4 expression in CD14 + HLA-DR − monocytes, and (f) TLR9 expression in CD14 + HLA-DR − monocytes. ∗ p < 0.05 versus unstimulated HV; ⌀ p < 0.05 versus stimulated HV; æ p < 0.05 TP versus corresponding TP stim; # p < 0.05 HV ctrl versus all; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.
    Mouse Anti Human Tlr4 Fitc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human tlr4 fitc/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    mouse anti human tlr4 fitc - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    fitc-conjugated mouse anti-human tlr1, tlr2, tlr4 and tlr6 antibodies  (Thermo Fisher)
    90
    Thermo Fisher fitc-conjugated mouse anti-human tlr1, tlr2, tlr4 and tlr6 antibodies
    Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed over a 10-day time course after admission (emergency department, ED–10) by flow cytometry. Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2 expression in CD14 + monocytes, (b) <t>TLR4</t> expression in CD14 + monocytes, (c) TLR9 expression in CD14 + monocytes, (d) TLR2 expression in CD14 + HLA-DR − monocytes, (e) TLR4 expression in CD14 + HLA-DR − monocytes, and (f) TLR9 expression in CD14 + HLA-DR − monocytes. ∗ p < 0.05 versus unstimulated HV; ⌀ p < 0.05 versus stimulated HV; æ p < 0.05 TP versus corresponding TP stim; # p < 0.05 HV ctrl versus all; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.
    Fitc Conjugated Mouse Anti Human Tlr1, Tlr2, Tlr4 And Tlr6 Antibodies, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc-conjugated mouse anti-human tlr1, tlr2, tlr4 and tlr6 antibodies/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    fitc-conjugated mouse anti-human tlr1, tlr2, tlr4 and tlr6 antibodies - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    fitc-conjugated mouse anti-human tlr4 antibody  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology fitc-conjugated mouse anti-human tlr4 antibody
    Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed over a 10-day time course after admission (emergency department, ED–10) by flow cytometry. Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2 expression in CD14 + monocytes, (b) <t>TLR4</t> expression in CD14 + monocytes, (c) TLR9 expression in CD14 + monocytes, (d) TLR2 expression in CD14 + HLA-DR − monocytes, (e) TLR4 expression in CD14 + HLA-DR − monocytes, and (f) TLR9 expression in CD14 + HLA-DR − monocytes. ∗ p < 0.05 versus unstimulated HV; ⌀ p < 0.05 versus stimulated HV; æ p < 0.05 TP versus corresponding TP stim; # p < 0.05 HV ctrl versus all; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.
    Fitc Conjugated Mouse Anti Human Tlr4 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc-conjugated mouse anti-human tlr4 antibody/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    fitc-conjugated mouse anti-human tlr4 antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed over a 10-day time course after admission (emergency department, ED–10) by flow cytometry. Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2 expression in CD14 + monocytes, (b) TLR4 expression in CD14 + monocytes, (c) TLR9 expression in CD14 + monocytes, (d) TLR2 expression in CD14 + HLA-DR − monocytes, (e) TLR4 expression in CD14 + HLA-DR − monocytes, and (f) TLR9 expression in CD14 + HLA-DR − monocytes. ∗ p < 0.05 versus unstimulated HV; ⌀ p < 0.05 versus stimulated HV; æ p < 0.05 TP versus corresponding TP stim; # p < 0.05 HV ctrl versus all; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.

    Journal: Mediators of Inflammation

    Article Title: Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients

    doi: 10.1155/2017/2608349

    Figure Lengend Snippet: Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed over a 10-day time course after admission (emergency department, ED–10) by flow cytometry. Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2 expression in CD14 + monocytes, (b) TLR4 expression in CD14 + monocytes, (c) TLR9 expression in CD14 + monocytes, (d) TLR2 expression in CD14 + HLA-DR − monocytes, (e) TLR4 expression in CD14 + HLA-DR − monocytes, and (f) TLR9 expression in CD14 + HLA-DR − monocytes. ∗ p < 0.05 versus unstimulated HV; ⌀ p < 0.05 versus stimulated HV; æ p < 0.05 TP versus corresponding TP stim; # p < 0.05 HV ctrl versus all; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.

    Article Snippet: Blood samples (100 μ l) were transferred into polystyrene FACS tubes (BD Pharmingen) and incubated with mouse anti-human CD14 V500 (Clone M5E2, BD Bioscience, San Jose, CA), mouse anti-human TLR2 PE-Cy7 (Clone T2.5, eBioscience, San Diego, CA), mouse anti-human TLR4 FITC (Clone HTA125, IMGENEX, San Diego, CA), mouse anti-human TLR9 Alexa Flour® 647 (Clone 26C593.2, IMGENEX, San Diego, CA), and mouse anti-human HLA-DR PerCP-Cy5.5 conjugated (Clone L243, BD Bioscience, San Jose, CA) antibodies.

    Techniques: Flow Cytometry, Incubation, Activation Assay, Expressing

    Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed by flow cytometry over a 10-day time course after admission (emergency department, ED–10). Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2/HLA-DR coexpression on CD14 + monocytes, (b) TLR4/HLA-DR coexpression on CD14 + monocytes, and (c) TLR9/HLA-DR coexpression on CD14 + monocytes. ∗ p < 0.05 versus unstimulated HV; æ p < 0.05 TP versus corresponding TP stim; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.

    Journal: Mediators of Inflammation

    Article Title: Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients

    doi: 10.1155/2017/2608349

    Figure Lengend Snippet: Whole blood from healthy volunteers (HV, n = 14) or major trauma patients (TP, n = 29) was analyzed by flow cytometry over a 10-day time course after admission (emergency department, ED–10). Monocytes were detected using anti-human CD14 in the corresponding sideward and forward scatter. Unstimulated (black symbols) and stimulated (clear symbols) measurements were made. For stimulation (stim), whole blood was incubated with leukocyte activation cocktail for 5 h with subsequent analyzing procedure as in unstimulated samples. Data are shown as mean ± SEM. (a) TLR2/HLA-DR coexpression on CD14 + monocytes, (b) TLR4/HLA-DR coexpression on CD14 + monocytes, and (c) TLR9/HLA-DR coexpression on CD14 + monocytes. ∗ p < 0.05 versus unstimulated HV; æ p < 0.05 TP versus corresponding TP stim; & p < 0.05 versus all; ∞ p < 0.05 TP stim versus corresponding unstimulated TP and HV stim.

    Article Snippet: Blood samples (100 μ l) were transferred into polystyrene FACS tubes (BD Pharmingen) and incubated with mouse anti-human CD14 V500 (Clone M5E2, BD Bioscience, San Jose, CA), mouse anti-human TLR2 PE-Cy7 (Clone T2.5, eBioscience, San Diego, CA), mouse anti-human TLR4 FITC (Clone HTA125, IMGENEX, San Diego, CA), mouse anti-human TLR9 Alexa Flour® 647 (Clone 26C593.2, IMGENEX, San Diego, CA), and mouse anti-human HLA-DR PerCP-Cy5.5 conjugated (Clone L243, BD Bioscience, San Jose, CA) antibodies.

    Techniques: Flow Cytometry, Incubation, Activation Assay